Europe's drugs regulator said on April 9 it was looking into Johnson & Johnson's (J&J) shot over reports of rare blood clots.

Four serious cases of rare blood clots with low platelets, one of which was fatal, have been reported after inoculation with J&J's vaccine from its Janssen unit, the European Medicines Agency (EMA) said.